Cancer Therapy
New cancer therapy study findings have been reported by scientists at University of Texas
Published in Genetics and Environmental Law Weekly, August 18th, 2007
A report, "Structural basis for the inhibition of the LSD1 histone demethylase by the antidepressant trans-2-phenylcyclopropylamine," is newly published data in Biochemistry. According to a study from the United States, "Histone modifications, such as acetylation and methylation, are important epigenetic marks that regulate diverse biological processes that use chromatin as the template, including transcription. Dysregulation of histone acetylation and methylation leads to the silencing of tumor suppressor genes and contributes to cancer progression."
"Inhibitors of enzymes that catalyze the addition and removal of these epigenetic marks thus have therapeutic...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Genetics and Environmental Law Weekly
More Articles from Genetics and Environmental Law Weekly
- Perinatology
Data on perinatology discussed by researchers at Yale University, Department of Genetics - Achondroplasia
Research from University of Copenhagen has provided new data on achondroplasia - Acute Lymphoblastic Leukemia
Researchers from Children's Hospital provide details of new studies and findings in the area of acute lymphoblastic leukemia - Acute Lymphoblastic Leukemia Prognosis
Researchers from University of Missouri publish new studies and findings in the area of acute lymphoblastic leukemia prognosis - Acute Myeloid Leukemia
Research from Indiana University in the area of acute myeloid leukemia described - Acute Promyelocytic Leukemia
Reports outline acute promyelocytic leukemia study results from R. Quere et al - More from this issue of Genetics and Environmental Law Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
